Figure 5.

Kaplan–Meier overall survival curves of subgroups of breast cancer patients according to IHC expression of GATA3. After adjusting for the patients’ age, GATA3 IHC positivity was associated with a significantly better overall survival in breast carcinoma patients with positive (+) estrogen receptors (ER) and progesterone receptor (PR), negative (−) HER2 and Ki-67 (i.e., <20%), and p53 wild-type IHC pattern and Luminal B intrinsic subtype. The age-adjusted hazard ratio (HR) for death and the 95% confidence interval (CI) estimated with Cox regression analyses are reported.